OBJECTIVES: Upon completion of this activity, the participant should be able to: 

Utilize Best Practice Alerts (BPA) and screening workflow/algorithm to increase the screening rate of patients meeting criteria for treatment resistant hypertension who may be at risk for primary hyperaldosteronism.

FACULTY DISCLOSURE:  Michael McNeal, MD has no relevant financial relationship(s) with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

PLANNER DISCLOSURE: Michael McNeal, MD and Jason Ramm, MD have no relevant financial relationship(s) to disclose with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Tresa McNeal, MD is a principal investigator for Dexcom. 

All relevant financial relationships have been mitigated.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of .50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.